DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Head and Neck Cancer Treatment Market 2017-2021" report to their offering.
The global head & neck cancer treatment market to grow at a CAGR of 8.07% during the period 2017-2021.
This report, Global Head & neck cancer treatment market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion operating in this market.
One trend in the market is outpatient care for head and neck cancer patients. Outpatient care for the cancer patients have been found to be equally effective compared with the inpatient care. In the outpatient treatment, the cancer patient can receive the treatment at their desired place, home being one of them.
According to the report, one driver in the market is rising incidence of head and neck cancer. Rising incidence of the head and neck cancer is the major factor leading to the higher demand of the drugs and treatment. Apart from alcohol and tobacco consumption, HPV infection is turning out to be one of the major causative agents responsible for rising incidence of the disease. Approximately 70-90% of new oropharyngeal cancers have evidence of HPV.
- Bristol-Myers Squibb
- Eli Lilly
Other prominent vendors:
- Dr. Reddy's Laboratories
- Sun Pharmaceutical Industries
- Takeda Pharmaceuticals
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Research Methodology
Part 04: Introduction
Part 05: Market introduction
Part 06: Pipe line landscape
Part 07: Market segmentation by cancer type
Part 08: Geographical segmentation
Part 09: Decision framework
Part 10: Drivers and challenges
Part 11: Market trends
Part 12: Vendor landscape
Part 13: Key vendor analysis
Part 14: Appendix
For more information about this report visit https://www.researchandmarkets.com/research/4kkz4w/global_head_and